Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Fidia Spa ( (IT:FDA) ) has shared an update.
Fidia S.p.A. has appointed Roberto Iammarino as its new chief financial officer, manager in charge of preparing the company’s accounting documents, and investor relations manager, consolidating key financial and market communication responsibilities under a single executive. The board’s decision follows a positive opinion from the Board of Statutory Auditors and reflects confidence in Iammarino’s extensive experience in auditing, financial management, M&A and corporate restructuring across major multinational groups, signaling a strengthening of Fidia’s governance and financial oversight structure as it pursues its strategic objectives.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global leader in numerical control technology and high-performance integrated milling systems. The group focuses on solutions for complex-shape milling, serving mainly the automotive mould sector and the aerospace industry with numerical controls, high-speed milling machines and CAM software.
Average Trading Volume: 1,421,178
Technical Sentiment Signal: Strong Sell
Current Market Cap: €711.8K
Find detailed analytics on FDA stock on TipRanks’ Stock Analysis page.